MEHLMAN CONSULTING, INC.

MEHLMAN CONSULTING, INC. filed a Q1 report for PODIMETRICS on April 17, 2026, reporting $60,000 in lobbying income.

Lobbying for PODIMETRICS · Care management company that produce medical devices to help prevent diabetic foot ulcers

All filings by MEHLMAN CONSULTING, INC. · Everything PODIMETRICS has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 17, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 5

Health Issues

Issues relating to diabetes care, diabetic foot ulcer monitoring, and amputation prevention.

Veterans

Issues relating to veterans' health and diabetes care, the VA Remote Patient Pedal Monitoring Program; diabetic foot ulcer monitoring and amputation prevention.

Medicare/Medicaid

Medicare coverage and reimbursement of technologies to improve care for diabetes patients and outcomes related to diabetes care, foot amputation prevention, and diabetic foot ulcers. Medicare and Medicaid quality improvement standards to promote reduction of amputation.

Manufacturing

Monitor issues relating to supply chain.

Budget/Appropriations

FY 2027 Appropriations - MILCON.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.